Business Opportunities

Cipla gets NPPA notice on overpricing drugs

The National Pharmaceutical Pricing Authority (NPPA) has sent a notice to Cipla for allegedly overcharging customers. The government arm has imposed a fine on the company for selling Ciprofloxacin and Doxycycline medicines at a higher price than the one stated by the government. - Reaction from double top - Cipla rises 4.3% - Sunny re-rating of pharma companies - Cipla shares jump on Pfizer talk - Cipla in talks with Pfizer, others for alliance - Pharma world discovers Bharat NPPA is an agency established to fix the prices of controlled bulk drugs. NPPA has asked the company to pay Rs 20.1 crore for Ciprofloxacin, this includes an amount of Rs 8.6 crore as interest charges, Cipla said in a statement to the Bombay Stock Exchange (BSE). Cipla said it has also been asked to pay Rs 1.1 lakh for Doxycycline. The period, for which these amounts pertain to, has not been specified in the demand notice, the company said. "These demands are contrary to the orders of the Supreme Court and the company has received legal advice that entire amounts demanded by the government are not tenable and sustainable," the company notification said. Shares of the company settled at Rs 351.50, down 1.99 per cent on the BSE today.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Top 5 Japanese carmakers post smaller output falls in Aug
Japan"s top five auto makers have reported smaller year-on-year declines in their global production in August compared with July, showing signs of a bottoming out in auto production.
Popular Articles
payday loans online

PE investments in South drops 64%
Private Equity (PE) investments into South India have dropped 64 per cent between April and September, 2009, to $626 million from $1752 million, during the same period last year. The number of deals fell 48 per cent. Among the four states in South, Andhra Pradesh had attracted the highest investment, in terms of value.

Downside breakout could test 4,800
The market crashed in the last two sessions with the Nifty bouncing from 4,955 level to close at 5,036 points for a week-on-week loss of 4.12 per cent. The Sensex was down 3.96 per cent, closing at 16,859 points. The Defty closed 4.93 per cent down as the rupee slid. Declines far outnumbered advances and volumes increased as prices fell. The broadbased BSE 500 dropped 4.3 per cent while the Midcap index dropped 5.4 per cent and the Junior was down 3.8 per cent. Domestic institutional investors were net buyers but FIIs sold heavily.